Bitrue has listed two new perpetual contracts, XBIUSDT and TQQQUSDT, giving traders leveraged exposure to a pair of closely watched U.S. equity sectors. XBI tracks the SPDR S&P Biotech ETF, offering broad exposure to the biotechnology sector, while TQQQ tracks the ProShares UltraPro QQQ, a leveraged fund built around the Nasdaq's largest technology companies.
Leveraged Exposure Without Holding the Underlying ETF
By offering these as perpetual contracts rather than spot tokens, Bitrue lets traders take leveraged long or short positions on biotech and big-tech-heavy Nasdaq exposure without needing to hold the ETFs themselves. The listing continues a trend among crypto exchanges of wrapping popular equity ETFs into perpetual products that trade continuously, rather than only during traditional market hours.
Timed Around Earnings Season
The listing lands in the middle of a heavy earnings week for large technology names, giving traders a way to position around volatility in the broader tech sector through the TQQQ contract specifically. Bitrue has been expanding its tokenized and derivative equity offerings in recent months as competition among exchanges for stock-linked trading products intensifies.
